Taiwan Blood-based Biomaker For Sports Medicine Market Size & Outlook
Taiwan blood-based biomaker for sports medicine market, 2018-2030 (US$M)
Related Markets
Taiwan blood-based biomaker for sports medicine market highlights
- The Taiwan blood-based biomaker for sports medicine market generated a revenue of USD 4.4 million in 2023 and is expected to reach USD 7.3 million by 2030.
- The Taiwan market is expected to grow at a CAGR of 7.3% from 2024 to 2030.
- In terms of segment, ck was the largest revenue generating type in 2023.
- CRP is the most lucrative type segment registering the fastest growth during the forecast period.
Blood-based biomaker for sports medicine market data book summary
| Market revenue in 2023 | USD 4.4 million |
| Market revenue in 2030 | USD 7.3 million |
| Growth rate | 7.3% (CAGR from 2023 to 2030) |
| Largest segment | Ck |
| Fastest growing segment | CRP |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6 |
Other key industry trends
- In terms of revenue, Taiwan accounted for 0.7% of the global blood-based biomaker for sports medicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China blood-based biomaker for sports medicine market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 25.9 million by 2030.
Ck was the largest segment with a revenue share of 18.18% in 2023. Horizon Databook has segmented the Taiwan blood-based biomaker for sports medicine market based on ck, myoglobin, lactate, wbc, urea, crp, lipid and protein hydroperoxides, il-6 covering the revenue growth of each sub-segment from 2018 to 2030.
Taiwan’s healthcare infrastructure is rapidly advancing, supported by robust government initiatives to enhance medical innovation and accessibility. The Taiwanese government has significantly invested in healthcare advancements, including developing & integrating cutting-edge technologies, such as blood based biomarkers in sports medicine.
These biomarkers are becoming increasingly important for monitoring athlete health and performance, offering precise insights into recovery, injury prevention, and overall well-being. Moreover, Taiwan’s increasing investment in the sports industry is expected to create more opportunities for participating and enhancing the overall sports ecosystem.
For instance, according to the National Science and Technology Council’s report from July 2022, the “Sports Everywhere” initiative aims to allocate around USD 154.6 million to enhance the competitiveness of elite athletes, encourage widespread physical activity among the public, and stimulate growth in the domestic sports technology sector. This surge in funding is being channeled into expanding sports facilities, developing youth programs, and promoting active lifestyles, which is expected to boost engagement in sports activities.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood-based Biomaker for Sports Medicine Market Scope
Blood-based Biomaker for Sports Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Taiwan blood-based biomaker for sports medicine market size, by type, 2018-2030 (US$M)
Taiwan Blood-based Biomaker for Sports Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
